Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

Metastatic breast cancer is an incurable form of breast cancer that exhibits high levels of epithelial-mesenchymal transition (EMT) markers. Angiotensin II has been linked to various signaling pathways involved in tumor cell growth and metastasis. The aim of this study is to investigate, for the fir...

Full description

Bibliographic Details
Main Authors: Rania Alaaeldin, Fares E. M. Ali, Amany Abdlrehim Bekhit, Qing-Li Zhao, Moustafa Fathy
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Molecules
Subjects:
azilsartan
breast cancer
NF-kB
EMT
IL-6/JAK2/STAT3
SLUG
Online Access:https://www.mdpi.com/1420-3049/27/22/7825

Internet

https://www.mdpi.com/1420-3049/27/22/7825

Similar Items